File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/hed.20432
- Scopus: eid_2-s2.0-33749363000
- PMID: 16823871
- WOS: WOS:000240849500001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: A 25-year experience
Title | Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: A 25-year experience |
---|---|
Authors | |
Keywords | Craniofacial Craniofacial resection Nose sinus tumor Sinonasal tumors |
Issue Date | 2006 |
Publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/38137 |
Citation | Head And Neck, 2006, v. 28 n. 10, p. 867-873 How to Cite? |
Abstract | Background. Craniofacial resection is the established "gold standard" for surgical treatment of tumors affecting the anterior skull base. Methods. This study analyzed 308 patients (220 males, 88 females) who had undergone craniofacial resection for sinonasal neoplasia with up to 25-year follow-up. Results. An overall actuarial survival of 65% at 5 years and 47% at 10 years was found for the cohort as a whole. For patients with malignant tumors, the 5-year actuarial survival was 59%, falling to 40% at 10 years. For patients with benign pathology, the actuarial survival was 92% at 5 years falling to 82% at 10 years. Statistical analysis again identified brain involvement, type of malignancy, and orbital involvement as the 3 most significant prognostic factors. Conclusion. Analysis of one of the largest single institution cohorts over a 25-year period provides a baseline against which other approaches such as an entirely endoscopic skull base resection must be judged. © 2006 Wiley Periodicals, Inc. |
Persistent Identifier | http://hdl.handle.net/10722/172928 |
ISSN | 2023 Impact Factor: 2.3 2023 SCImago Journal Rankings: 1.034 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Howard, DJ | en_US |
dc.contributor.author | Lund, VJ | en_US |
dc.contributor.author | Wei, WI | en_US |
dc.date.accessioned | 2012-10-30T06:25:50Z | - |
dc.date.available | 2012-10-30T06:25:50Z | - |
dc.date.issued | 2006 | en_US |
dc.identifier.citation | Head And Neck, 2006, v. 28 n. 10, p. 867-873 | en_US |
dc.identifier.issn | 1043-3074 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/172928 | - |
dc.description.abstract | Background. Craniofacial resection is the established "gold standard" for surgical treatment of tumors affecting the anterior skull base. Methods. This study analyzed 308 patients (220 males, 88 females) who had undergone craniofacial resection for sinonasal neoplasia with up to 25-year follow-up. Results. An overall actuarial survival of 65% at 5 years and 47% at 10 years was found for the cohort as a whole. For patients with malignant tumors, the 5-year actuarial survival was 59%, falling to 40% at 10 years. For patients with benign pathology, the actuarial survival was 92% at 5 years falling to 82% at 10 years. Statistical analysis again identified brain involvement, type of malignancy, and orbital involvement as the 3 most significant prognostic factors. Conclusion. Analysis of one of the largest single institution cohorts over a 25-year period provides a baseline against which other approaches such as an entirely endoscopic skull base resection must be judged. © 2006 Wiley Periodicals, Inc. | en_US |
dc.language | eng | en_US |
dc.publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/38137 | en_US |
dc.relation.ispartof | Head and Neck | en_US |
dc.rights | Head & Neck. Copyright © John Wiley & Sons, Inc. | - |
dc.subject | Craniofacial | - |
dc.subject | Craniofacial resection | - |
dc.subject | Nose sinus tumor | - |
dc.subject | Sinonasal tumors | - |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Aged, 80 And Over | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Cohort Studies | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-Up Studies | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Nasal Cavity | en_US |
dc.subject.mesh | Nose Neoplasms - Mortality - Surgery | en_US |
dc.subject.mesh | Otorhinolaryngologic Surgical Procedures - Methods | en_US |
dc.subject.mesh | Paranasal Sinus Neoplasms - Mortality - Surgery | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.subject.mesh | Skull Base | en_US |
dc.subject.mesh | Survival Rate | en_US |
dc.subject.mesh | Time Factors | en_US |
dc.title | Craniofacial resection for tumors of the nasal cavity and paranasal sinuses: A 25-year experience | en_US |
dc.type | Article | en_US |
dc.identifier.email | Wei, WI: hrmswwi@hku.hk | en_US |
dc.identifier.authority | Wei, WI=rp00323 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1002/hed.20432 | en_US |
dc.identifier.pmid | 16823871 | - |
dc.identifier.scopus | eid_2-s2.0-33749363000 | en_US |
dc.identifier.hkuros | 122870 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-33749363000&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 28 | en_US |
dc.identifier.issue | 10 | en_US |
dc.identifier.spage | 867 | en_US |
dc.identifier.epage | 873 | en_US |
dc.identifier.isi | WOS:000240849500001 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Howard, DJ=7202305361 | en_US |
dc.identifier.scopusauthorid | Lund, VJ=7102840344 | en_US |
dc.identifier.scopusauthorid | Wei, WI=7403321552 | en_US |
dc.identifier.issnl | 1043-3074 | - |